Metropolitan Life Insurance CO Iovance Biotherapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$7.59 - $17.47 $6,770 - $15,583
-892 Reduced 6.67%
12,474 $184,000
Q3 2023

Nov 14, 2023
BUY
$4.44 - $8.79 $8,866 - $17,553
1,997 Added 17.57%
13,366 $60,000
Q2 2023

Aug 10, 2023
BUY
$5.36 - $9.06 $60,937 - $103,003
11,369 New
11,369 $80,000
Q4 2022

Jun 14, 2023
BUY
$5.62 - $10.0 $51,248 - $91,190
9,119 New
9,119 $58.3 Million
Q3 2022

Jun 14, 2023
BUY
$9.53 - $13.11 $86,904 - $119,550
9,119 New
9,119 $87.4 Million
Q2 2022

Jun 20, 2023
BUY
$6.38 - $18.33 $58,179 - $167,151
9,119 New
9,119 $100,000
Q2 2022

Mar 30, 2023
BUY
$6.38 - $18.33 $25,756 - $73,998
4,037 Added 79.44%
9,119 $100,000
Q2 2022

Aug 11, 2022
BUY
$6.38 - $18.33 $58,179 - $167,151
9,119 New
9,119 $101,000
Q1 2022

May 12, 2022
SELL
$12.38 - $19.1 $62,915 - $97,066
-5,082 Closed
0 $0
Q4 2021

Jun 21, 2023
BUY
$16.55 - $27.63 $84,107 - $140,415
5,082 New
5,082 $97,000
Q4 2021

Mar 30, 2023
BUY
$16.55 - $27.63 $34,424 - $57,470
2,080 Added 69.29%
5,082 $97,000
Q4 2021

Feb 15, 2022
BUY
$16.55 - $27.63 $34,424 - $57,470
2,080 Added 69.29%
5,082 $97,000
Q3 2021

Jun 21, 2023
BUY
$20.35 - $26.63 $102,564 - $134,215
5,040 New
5,040 $124,000
Q3 2021

Mar 30, 2023
SELL
$20.35 - $26.63 $43,630 - $57,094
-2,144 Reduced 41.66%
3,002 $74,000
Q3 2021

Nov 15, 2021
SELL
$20.35 - $26.63 $43,630 - $57,094
-2,144 Reduced 41.66%
3,002 $74,000
Q2 2021

Mar 30, 2023
SELL
$16.33 - $33.07 $79,478 - $160,951
-4,867 Reduced 48.61%
5,146 $133,000
Q2 2021

Aug 16, 2021
BUY
$16.33 - $33.07 $83,870 - $169,847
5,136 Added 51360.0%
5,146 $134,000
Q1 2021

Jun 26, 2023
BUY
$28.67 - $52.59 $287,072 - $526,583
10,013 New
10,013 $317 Million
Q1 2021

Mar 30, 2023
SELL
$28.67 - $52.59 $12,930 - $23,718
-451 Reduced 4.31%
10,013 $317,000
Q1 2021

May 14, 2021
SELL
$28.67 - $52.59 $299,716 - $549,775
-10,454 Reduced 99.9%
10 $317,000
Q4 2020

Jun 22, 2023
BUY
$28.04 - $50.26 $293,410 - $525,920
10,464 New
10,464 $485,000
Q4 2020

Mar 30, 2023
SELL
$28.04 - $50.26 $5,720 - $10,253
-204 Reduced 1.91%
10,464 $485,000
Q4 2020

Feb 16, 2021
SELL
$28.04 - $50.26 $5,720 - $10,253
-204 Reduced 1.91%
10,464 $486,000
Q3 2020

Jun 26, 2023
BUY
$27.75 - $36.3 $296,037 - $387,248
10,668 New
10,668 $351,000
Q3 2020

Mar 30, 2023
SELL
$27.75 - $36.3 $2,136 - $2,795
-77 Reduced 0.72%
10,668 $351,000
Q3 2020

Nov 13, 2020
SELL
$27.75 - $36.3 $2,136 - $2,795
-77 Reduced 0.72%
10,668 $351,000
Q2 2020

Jun 26, 2023
BUY
$27.21 - $41.0 $292,371 - $440,545
10,745 New
10,745 $294,000
Q2 2020

Mar 30, 2023
SELL
$27.21 - $41.0 $672,603 - $1.01 Million
-24,719 Reduced 69.7%
10,745 $294,000
Q2 2020

Aug 14, 2020
SELL
$27.21 - $41.0 $672,603 - $1.01 Million
-24,719 Reduced 69.7%
10,745 $295,000
Q1 2020

Jul 12, 2023
BUY
$19.54 - $38.85 $692,966 - $1.38 Million
35,464 New
35,464 $1.06 Million
Q1 2020

Mar 30, 2023
SELL
$19.54 - $38.85 $21,376 - $42,501
-1,094 Reduced 2.99%
35,464 $1.06 Million
Q1 2020

May 15, 2020
SELL
$19.54 - $38.85 $21,376 - $42,501
-1,094 Reduced 2.99%
35,464 $1.06 Million
Q4 2019

Jul 12, 2023
BUY
$17.95 - $29.41 $656,216 - $1.08 Million
36,558 New
36,558 $1.01 Million
Q4 2019

Mar 30, 2023
SELL
$17.95 - $29.41 $12,241 - $20,057
-682 Reduced 1.83%
36,558 $1.01 Million
Q4 2019

Feb 14, 2020
SELL
$17.95 - $29.41 $12,241 - $20,057
-682 Reduced 1.83%
36,558 $1.01 Million
Q3 2019

Jul 12, 2023
BUY
$17.99 - $26.0 $669,947 - $968,240
37,240 New
37,240 $677,000
Q3 2019

Mar 30, 2023
BUY
$17.99 - $26.0 $33,371 - $48,230
1,855 Added 5.24%
37,240 $677,000
Q3 2019

Nov 14, 2019
BUY
$17.99 - $26.0 $33,371 - $48,230
1,855 Added 5.24%
37,240 $678,000
Q2 2019

Jul 12, 2023
BUY
$9.78 - $24.52 $346,065 - $867,640
35,385 New
35,385 $867,000
Q1 2019

Jul 13, 2023
BUY
$8.41 - $11.26 $297,587 - $398,435
35,385 New
35,385 $336,000
Q1 2019

Mar 30, 2023
BUY
$8.41 - $11.26 $220,897 - $295,755
26,266 Added 288.04%
35,385 $336,000
Q1 2019

May 16, 2019
BUY
$8.41 - $11.26 $229,567 - $307,364
27,297 Added 337.5%
35,385 $336,000
Q1 2019

May 15, 2019
SELL
$8.41 - $11.26 $229,567 - $307,364
-27,297 Reduced 77.14%
8,088 $256,000
Q4 2018

Jul 13, 2023
BUY
$7.51 - $11.93 $265,741 - $422,143
35,385 New
35,385 $313,000
Q4 2018

Feb 14, 2019
BUY
$7.51 - $11.93 $220,718 - $350,622
29,390 Added 490.24%
35,385 $313,000
Q3 2018

Jul 13, 2023
BUY
$11.25 - $17.7 $307,968 - $484,537
27,375 New
27,375 $308 Million
Q3 2018

Nov 14, 2018
BUY
$11.25 - $17.7 $67,443 - $106,111
5,995 New
5,995 $67,000

Others Institutions Holding IOVA

# of Institutions
313
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email